Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoprotein Lipase Deficiency”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableUnknownNCT01448577
What this trial is testing

Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies

Who this might be right for
Lipoprotein Lipase Deficiency
Amsterdam Molecular Therapeutics 22
Not applicableWithdrawnNCT03198897
What this trial is testing

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

Who this might be right for
Lipoprotein Lipase DeficiencyInborn Error of Lipid MetabolismCorneal Arcus
CENTOGENE GmbH Rostock
Testing effectiveness (Phase 2)Study completedNCT02098278
What this trial is testing

Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

Who this might be right for
Lipoprotein Lipase Deficiency, FamilialHyperlipoproteinemia Type IChylomicronemia, Familial+1 more
Catabasis Pharmaceuticals 13
Testing effectiveness (Phase 2)Study completedNCT01146522
What this trial is testing

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

Who this might be right for
Hyperlipoproteinemia
Novartis Pharmaceuticals 8
Large-scale testing (Phase 3)Study completedNCT05902598
What this trial is testing

ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia Syndrome
Visirna Therapeutics HK Limited 37
Testing effectiveness (Phase 2)Study completedNCT02767531
What this trial is testing

Orlistat for the Treatment of Type I Hyperlipoproteinemia

Who this might be right for
Hyperlipoproteinemia Type IHypertriglyceridemia
University of Texas Southwestern Medical Center 2
Large-scale testing (Phase 3)Study completedNCT01514461
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia Syndrome (FCS)
Novartis Pharmaceuticals 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05185843
What this trial is testing

Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen

Who this might be right for
Familial Chylomicronemia Syndrome
Ionis Pharmaceuticals, Inc. 24
Not applicableAvailableNCT06796426
What this trial is testing

Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS

Who this might be right for
Familial ChylomicronemiaHigh Risk Severe Hypertriglyceridemia (SHTG)
Arrowhead Pharmaceuticals
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Large-scale testing (Phase 3)Ended earlyNCT01589237
What this trial is testing

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Who this might be right for
Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT06471543
What this trial is testing

Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects

Who this might be right for
HypertriglyceridemiaFamilial Chylomicronemia Syndrome
Ikaria Bioscience Pty Ltd 108
Testing effectiveness (Phase 2)Study completedNCT03360747
What this trial is testing

Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)

Who this might be right for
Familial Chylomicronemia SyndromeLipoprotein Lipase DeficiencyHyperlipoproteinemia Type 1
Akcea Therapeutics 3
Not applicableStudy completedNCT03912181
What this trial is testing

Medical Complications in Familial and Multifactorial Chylomicronaemia Syndromes

Who this might be right for
Familial Chylomicronemia SyndromeMultifactorial Chylomicronemia Syndrome
Hospices Civils de Lyon 140
Not applicableStudy completedNCT02656095
What this trial is testing

Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment

Who this might be right for
Lipoprotein Lipase Deficiency
University of Colorado, Denver 12
Not applicableEnded earlyNCT01447901
What this trial is testing

Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

Who this might be right for
Hyperlipoproteinemia Type I
Amsterdam Molecular Therapeutics 19
Testing effectiveness (Phase 2)WithdrawnNCT02904772
What this trial is testing

Alipogene Tiparvovec for the Treatment of LPLD Patients

Who this might be right for
LPL Deficiency
UniQure Biopharma B.V.
Large-scale testing (Phase 3)Study completedNCT02658175
What this trial is testing

The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia SyndromeLipoprotein Lipase DeficiencyHyperlipoproteinemia Type 1
Akcea Therapeutics 68
Not applicableLooking for participantsNCT04227678
What this trial is testing

Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

Who this might be right for
Lipoprotein Lipase Deficiency
Université de Sherbrooke 16
Not applicableNo Longer AvailableNCT03544060
What this trial is testing

Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS)

Who this might be right for
Familial Chylomicronemia
Akcea Therapeutics
Load More Results